Actively Recruiting
Short-term Glucocorticoid Combined with MMF for IgG4-RD
Led by Wen Zhang · Updated on 2024-10-29
63
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Comparison of short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease
CONDITIONS
Official Title
Short-term Glucocorticoid Combined with MMF for IgG4-RD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Diagnosed with IgG4-Related Disease by 2020 Japan or 2019 ACR/EULAR criteria
- Active IgG4-RD with at least one organ showing a reaction score of 2 or more
- No previous medication or recurrence after stopping treatment
You will not qualify if you...
- Having another main autoimmune disease
- Pregnant or breastfeeding women
- Having a malignant tumor
- Active bacterial, fungal, viral, or mycobacterial infection
- Severe complications in important organs with expected survival less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100050
Actively Recruiting
Research Team
L
Linyi Peng, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here